As shown in Figure 12A, in line with previous reports showing decreased expression of HMGCS2 in human MASH patients [16], we found the number of exon-mapped reads was much lower for HMGCS2. This evidence concerns the gene HMGCS2 and metabolic dysfunction-associated steatohepatitis.